Skip to main navigation

- Silverback - Corp Menu

  • About
    • Team
    • Management Team
    • Board of Directors
  • Science & Technology
    • ImmunoTAC® Platform
    • Tumor-Localized Myeloid Cell Activation
    • Publications
  • Pipeline
    • SBT6050
    • SBT6290
    • SBT8230
    • Additional Oncology Programs
    • Fibrosis Program
  • Careers
    • Open Positions
  • Contact
  • Investors
    • Overview
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financials & Filings
    • IR Resources
    Careers
    Silverback Logo
    Silverback Logo

    SEC Filing Details

    - Silverback - Investor Relations

    • Home
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
    • IR Resources
      • Email Alerts
      • Contact IR

    Document Details

    Form
    8-K
    Filing Date
    Mar 17, 2022
    Document Date
    Mar 11, 2022
    Form Description
    Report of unscheduled material events or corporate event
    Filing Group
    Current Reports
    Company
    Silverback Therapeutics Inc
    Issuer
    Silverback Therapeutics, Inc.

    Filing Formats

    iXBRL
    View HTML
    Download PDF
    Download DOC
    Download XLS

    XBRL

    XBRL Viewer
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
    EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
    XML - XBRL INSTANCE DOCUMENT

    - Silverback - Investor Tools

    • Print Page
    • RSS Feeds
    • Email Alerts

    - Silverback - Corp Menu

    • About
      • Team
      • Management Team
      • Board of Directors
    • Science & Technology
      • ImmunoTAC® Platform
      • Tumor-Localized Myeloid Cell Activation
      • Publications
    • Pipeline
      • SBT6050
      • SBT6290
      • SBT8230
      • Additional Oncology Programs
      • Fibrosis Program
    • Careers
      • Open Positions
    • Contact
    • Investors
      • Overview
      • News & Events
      • Stock Information
      • Corporate Governance
      • Financials & Filings
      • IR Resources
    © Copyright 2022 - Silverback Therapeutics®
    Scroll to top